We Work for Health of Massachusetts seeks to educate our elected leaders, the news media and the communities they serve about the important contributions these companies and their employees make to the health and economic security of individuals, local communities, and to the Commonwealth of Massachusetts.

The industry not only helps drive the Massachusetts economy, but also leads the world in life-saving research and supports a vibrant patient advocacy community. Biopharmaceutical research companies and their employees play a critical role in improving the health and well-being of Massachusetts’ patients by delivering life-saving, life-enhancing advancements in medicine. In addition to working to improve health and economic viability, many biopharmaceutical companies provide philanthropic outreach in local communities across Massachusetts through grants and programs supporting access to affordable health coverage and medicine, primary and secondary education, social services, arts, and other community needs.

The biopharmaceutical sector is the foundation of one of Massachusetts’ most dynamic innovation and business ecosystems. Not only does the industry invest heavily in the research and development of new treatments and cures, it also generates high quality jobs, powers economic output and exports for the U.S. economy and sustains a very large-scale supply chain.


Supporting High Quality Jobs in Massachusetts

The innovative biopharmaceutical sector directly supported 60,738 jobs in Massachusetts in 2017. These jobs are often high-skill, high-wage professions.

The industry also supported another 223,621 jobs indirectly, for a total of about 284,359 jobs across the Massachusetts economy. These additional jobs are with vendors and suppliers such as construction companies and I.T. companies, and jobs generated by the sector’s employees such as day care centers and restaurants.

Massachusetts workers whose jobs were supported by the biopharmaceutical sector paid a total of $5.4 billion in personal taxes in 2017—$4.8 billion in federal taxes and $676.8 million in state taxes.

Massachusetts' Economic Impact

In 2017, the biopharmaceutical sector supported $70.9 billion in economic output for the state of Massachusetts—including $29.6 billion generated directly by the sector, and another $41.2 billion through its vendors and suppliers and through the economic activity of its workforce.

Direct Output per Direct Employee in 2017

$29.6 Billion
$41.2 Billion
$70.9 Billion

vendor relationships


vendor spending


Find Your
Elected Officials



Peter Forman, President & CEO, South Shore Chamber of Commerce



ACS-CAN Massachusetts

AIDS Action Committee

Astellas Pharma

Asthma and Allergy Association of America, New England (AAFANE)


Blackstone Valley Chamber of Commerce 

Cambridge Chamber of Commerce

Cure Duchenne

DGL Healthcare Consulting

Jewish Vocational Service (JVS)

Kendall Square Association

Life Science Cares


Lupus Foundation New England

Mass Bio

Mass Biomedical Initiatives

Mass Manufacturing Extension Partnership (MassMEP)

Massachusetts Association For Mental Health (MAMH)

National Kidney Foundation, New England

Network for Excellence in Health Innovation (NEHI)

New England Venture Capital Association

Otsuka Pharmaceutical

Quincy College- Biotechnology & Good Manufacturing Practice Program

Rare New England

South Shore Chamber of Commerce


Takeda Pharmaceuticals

Worcester Regional Chamber of Commerce


If your organization is interested in joining We Work For Health Massachusetts, please click the "Join" button below.